IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1501
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$2.0B
Roger A. Jeffs
Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$LQDA Liquidia Corp | 53 | 65 | 47 | 76 | - | 353.4x | -483.6% | -38.6% | 58.1% | -553.2% | -556.8% | 1385.2% | 0.0% | 1152.0x | $2.0B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
Liquidia Corp (LQDA) receives a "Hold" rating with a composite score of 53.2/100. It ranks #1501 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Roger A. Jeffs
Chief Executive Officer
Labor Force
50
65
17
51
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for LQDA
Outperforming peers — winners tend to keep winning over 3-12 months
Fair valuation relative to peers
High profitability & efficiency — strong quality floor supports entry
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for LQDA.
View All RatingsImproving capital utilization rates confirmed
High margin volatility — erratic forensic earnings quality
ROIC 4.0% vs WACC 9.3% (spread -5.3%)
GM 58% vs sector 43%, OM -553% vs sector 1%
Capital turnover 1.55x, R&D intensity 33.7%
Rev growth 1385%, 6yr history
Interest coverage 0.3x, Net debt/EBITDA 16.9x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns Liquidia Corp a Hold rating, with a composite score of 53.2/100 and 3 out of 5 stars. Ranked #1501 of 7,333 stocks, LQDA presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
LQDA earns a quality score of 65/100, indicating above-average business quality. The company reports a return on equity of -483.6% (sector avg: -2.5%), gross margins of 58.1% (sector avg: 42.5%), net margins of -556.8% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
With a value score of 47/100, LQDA appears somewhat expensive relative to its fundamentals. Key valuation metrics include an EV/EBITDA of 353.43x, a P/B ratio of 132.51x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
Liquidia Corp's investment score of 17/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 1385.2% vs. a sector average of 5.9% and a return on assets of -38.6% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
LQDA shows strong momentum characteristics with a score of 76/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at 1385.2% year-over-year, while a beta of 1.12 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
With a stability score of 51/100, LQDA exhibits average financial resilience. Key stability metrics include a beta of 1.12 and a debt-to-equity ratio of 1152.00x (sector avg: 0.2x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
Liquidia Corp's short interest score of 34/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 1152.00x), small-cap liquidity risk. At $2.0B (small-cap), LQDA carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
Liquidia Corp is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1501 of 7,333 overall (80th percentile). Key comparisons include ROE of -483.6% trailing the -2.5% sector median and operating margins of -553.2% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While LQDA currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Momentum (76) vs Investment (17) — closing this gap could shift the rating.
EV/EBITDA 2984% ABOVE SECTOR MEDIAN
ROE 19398% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 37% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate Liquidia Corp (LQDA) as a Hold with a composite score of 53.2/100 at a current price of $33.60. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in momentum (76th percentile) and quality (65th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (17th percentile) and value (47th percentile) tempers our overall conviction. We assign a No Moat rating (37/100), High uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress; sustainability of the current growth rate; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Liquidia Corp holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 53.2/100 places it at rank #1501 in our full 7,333-stock universe. At $2.0B in market capitalization, Liquidia Corp is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
The near-term outlook is constructive, with revenue growing at 1385% and momentum in the 76th percentile confirming positive market sentiment and institutional accumulation. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy. Investment factor at the 17th percentile indicates reinvestment patterns that investors should monitor for sustainability.
The margin cascade tells an important story: gross margins of 58% (+15.6pp vs sector) narrow to operating margins of -553% (-554.5pp vs sector) and net margins of -556.8%, yielding a gross-to-net conversion rate of -958%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $33.60, Liquidia Corp is trading near fair value based on current fundamentals. Our value factor score of 47/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at EV/EBITDA of 353.4x (at a premium), P/B of 132.5x, P/S of 41.3x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Gross margins of 58% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 1385% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
Positive momentum (76th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
Elevated leverage (1152% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of -556.8% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a High uncertainty rating to Liquidia Corp. Key risk factors include significant leverage (1152% debt-to-equity), current negative profitability (net margin -556.8%), the combination of leverage (1152% D/E) and thin margins (-556.8% net) amplifies downside risk. The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: significant leverage (1152% debt-to-equity); current negative profitability (net margin -556.8%); the combination of leverage (1152% D/E) and thin margins (-556.8% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 51th percentile and quality factor at the 65th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 58% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate Liquidia Corp's capital allocation as Poor. Key concerns include low returns on equity (-483.6%), elevated leverage (1152% D/E), negative profitability, weak asset returns (ROA -38.6%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Liquidia Corp significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Liquidia Corp receives a Hold rating with a composite score of 53.2/100 (rank #1501 of 7,333). Our quantitative framework assigns a No Moat (37/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 51/100.
Our analysis supports a neutral stance on Liquidia Corp. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Liquidia Corp a meaningful economic moat, scoring 37/100 on our composite assessment. The ROIC-WACC spread of -5.3% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 10.8/20.
The strongest moat sources are margin superiority (10.8/20) and growth durability (10.7/20). GM 58% vs sector 43%, OM -553% vs sector 1%. Rev growth 1385%, 6yr history. These pillars form the core of Liquidia Corp's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include financial resilience (0/20) and economic value creation (6/20). Interest coverage 0.3x, Net debt/EBITDA 16.9x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Liquidia Corp's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 58% providing a solid profitability foundation, robust top-line growth of 1385% expanding the revenue base. The margin cascade from 58% gross to -553% operating to -556.8% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 65th percentile.
The margin profile shows gross margins of 58%, operating margins of -553%, net margins of -556.8%. Return metrics include ROE of -483.6% and ROA of -38.6%. Relative to the Manufacturing sector, gross margins are 15.6 percentage points above the sector median of 43%, and ROE of -483.6% compares to a sector median of -2.5%.
The balance sheet reflects high leverage with D/E of 1152%, which may limit financial flexibility, revenue growth of 1385%. The sector median D/E is 0%, putting Liquidia Corp at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Above 50MA
37.18%
Net New Highs
+51081
Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...
Recently, Liquidia Corp was identified as meeting the Minervini Trend Template, reflecting strong technical momentum alongside very large year-over-year revenue growth and upgraded analyst revenue forecasts. This combination of exceptional top-line expansion and positive revisions has positioned Liquidia as a market leader in its niche, attracting heightened investor attention even as volatility remains elevated. Next, we will explore how Liquidia’s very large revenue growth and upgraded...
Arquitos Capital Partners, an investment management firm, released its Q4 2025 investor letter. A copy of the letter can be downloaded here. Arquitos Capital Management reported a standout year in which the fund returned 82.1% net of fees in 2025, significantly outperforming the Russell 2000’s 12.8% gain. The manager noted that market conditions became increasingly […]

Liquidia Corporation will present two oral presentations at the CHEST 2025 annual meeting, focusing on clinical data from its ASCENT trial for LIQ861 DPI treprostinil in pulmonary hypertension-interstitial lung disease (PH-ILD) patients, highlighting safety and exploratory efficacy data.
EXEL vs. LQDA: Which Stock Is the Better Value Option?